Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1093/cid/ciad638 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Timing of testing affects earwitness memory.
Mem Cognit
November 2024
Tufts University, 490 Boston Ave, Medford, MA, 02155, USA.
The present experiments investigated how interpolated testing and postevent misinformation affected earwitness memory. We examined how the number of tests and when tests occurred affected memory for an overheard event and source monitoring. Across three experiments, participants overheard a crime (i.
View Article and Find Full Text PDFUnderstanding discourse in face-to-face settings: The impact of multimodal cues and listening conditions.
J Exp Psychol Learn Mem Cogn
October 2024
Department of Experimental Psychology, University College London.
In face-to-face contexts, discourse is accompanied by various cues, like gestures and mouth movements. Here, we asked whether the presence of gestures and mouth movements benefits discourse comprehension under clear and challenging listening conditions and, if so, whether this multimodal benefit depends on the communicative environment in which interlocutors are situated. In two online experiments, participants watched videoclips of a speaker telling stories, and they answered yes-no questions about the content of each story.
View Article and Find Full Text PDFThe Anthropussy: an ecolesbian manifesto.
J Lesbian Stud
June 2024
Politics, Philosophy, & Economics, Singapore.
The Anthropocene is old news. As young queer zine-makers in Singapore, we heard the term on repeat and dared to ask: What about the Anthro? From this queer environmentalist pun we birthed a new take on our relationship to the Earth amidst climate crises - and in doing so, we came out as ecolesbians. Ecolesbianism is a concept we co-created, bringing together queer ecologies, political lesbianism, ecofeminism, transecology, ecosexuality, and our own experiences.
View Article and Find Full Text PDFEfficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials.
Lancet
June 2024
European Hidradenitis Suppurativa Foundation, Dessau, Germany; Departments of Dermatology, Venereology, Allergology, and Immunology, Staedtisches Klinikum Dessau, Brandenburg Medical School Theodor Fontane and Faculty of Health Sciences Brandenburg, Dessau, Germany.
Article Synopsis
- Bimekizumab, a monoclonal antibody targeting IL-17F and IL-17A, is being tested as a treatment for moderate-to-severe hidradenitis suppurativa, a condition with limited treatment options.
- The BE HEARD I and II trials were 48-week, randomized, double-blind studies that evaluated the efficacy and safety of various dosing regimens of bimekizumab compared to a placebo in over 1,000 patients.
- Results showed significant improvement in patients receiving bimekizumab every 2 weeks, meeting the primary efficacy goal of at least a 50% reduction in disease symptoms by week 16.
Evidence-based recruitment strategies for clinical research: Study personnel's and research participants' perceptions about successful methods of outreach for a U.S. Autism-Research Cohort.
J Clin Transl Sci
April 2024
Simons Foundation, New York, NY, USA.
Introduction: Under enrollment of participants in clinical research is costly and delays study completion to impact public health. Given that research personnel make decisions about which strategies to pursue and participants are the recipients of these efforts, we surveyed research staff ( = 52) and participants ( = 4,144) affiliated with SPARK (Simons Foundation Powering Autism for Knowledge) - the largest study of autism in the U.S.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!